Evidence map›Paper›PMID 39507493›Full record

ArticleFrontiers in pediatrics2024

Infant formula with added

Carol Lynn Berseth, Michael Yeiser, Cheryl L Harris, Jennifer N Kinnaman, Victoria Lappin, Jennifer L Wampler, Weihong Zhuang, Jon Vanderhoof

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01897922 (The Effects on Growth and Tolerance of an Infant Formula Fed to Term Infants), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01897922 nacompletednot on this map

The Effects on Growth and Tolerance of an Infant Formula Fed to Term Infants

TypeinterventionalSponsorMead Johnson NutritionRan2013 to 2014Enrolled348ConditionsGrowth of Term InfantsArmsAn investigational infant formula containing a probiotic source, Control: Marketed routine infant formula
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Carol Lynn BersethMedical Sciences, Reckitt | Mead Johnson Nutrition, Evansville, IN, United States.
Michael YeiserOwensboro Pediatrics, Owensboro, KY, United States.
Cheryl L HarrisMedical Sciences, Reckitt | Mead Johnson Nutrition, Evansville, IN, United States.
Jennifer N KinnamanNutrition Sciences, Reckitt | Mead Johnson Nutrition, Evansville, IN, United States.
Victoria LappinClinical Research, Research & Development, Reckitt, Hull, United Kingdom.
Jennifer L WamplerMedical Sciences, Reckitt | Mead Johnson Nutrition, Evansville, IN, United States.
Weihong ZhuangMedical Sciences, Reckitt | Mead Johnson Nutrition, Evansville, IN, United States.
Jon VanderhoofGastroenterology, Boston Children's Hospital, Boston, MA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Lacticaseibacillus rhamnosus GG (LGG) is a well-studied probiotic with a history of safe use. Methods: In this double-blind, prospective study, growth and tolerance were evaluated in healthy term infants randomized to: marketed, routine intact cow's milk protein-based formula (Control, Results: Of 351 infants enrolled, 275 completed (Control, Discussion: In healthy term infants, a routine intact cow's milk protein-based formula with added LGG supported adequate growth and was well tolerated. Further studies are needed to evaluate potential benefits for fussiness and efficacy outcomes. Clinical Trial Registration: Clinicaltrials.gov, identifier (NCT01897922).

Indexed as

healthy growthinfant formulaLacticaseibacillus rhamnosus GGpediatric nutritionterm infant

Identifiers

PMID39507493
PMCPMC11538007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.